Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function

Journal of Hepatology

Volumn 58, Issue 6, 2013, Pages 1125-1132

  Du Plessis, Johannie ^a   Vanheel, Hanne ^c   Janssen, Carl E I ^b   Roos, Leonie ^a   Slavik, Tomas ^a   Stivaktas, Paraskevi I ^a   Nieuwoudt, Martin ^a   Van Wyk, Stefan G ^a   Vieira, Warren ^a   Pretorius, Etheresia ^a   Beukes, Mervyn ^a   Farré, Ricard ^c   Tack, Jan ^c   Laleman, Wim ^b   Fevery, Johan ^b   Nevens, Frederik ^b   Roskams, Tania ^b   Van Der Merwe, Schalk W ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bacterial translocation; Cirrhosis; Epithelial barrier; IL 6; Intestinal macrophages; Nitric oxide

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CHEMOKINE; CLAUDIN 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; IL6 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM; DUODENUM BIOPSY; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SUPERNATANT; TIGHT JUNCTION; TISSUE CULTURE; UPREGULATION; WESTERN BLOTTING; IMMUNOLOGY; INTESTINE; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; METABOLISM; MIDDLE AGED; PERMEABILITY; SECRETION (PROCESS);

AGED; ANTIGENS, CD14; FEMALE; HUMANS; INTERLEUKIN-6; INTESTINES; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PERMEABILITY;

EID: 84877924539     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.01.038     Document Type: Article

References (30)

1. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256
2. P. Zapater, R. Francés, J.M. González-Navajas, M.A. de la Hoz, R. Moreu, and S. Pascual Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis Hepatology 48 2008 1924 1931
3. P. Bellot, J.C. García-Pagán, R. Francés, J.G. Abraldes, M. Navasa, and M. Perez-Mateo Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis Hepatology 52 2010 2044 2052
4. J.R. Turner Intestinal mucosal barrier function in health and disease Nat Rev Immunol 9 2009 799 809
5. A.M. Marchiando, W.V. Graham, and J.R. Turner Epithelial barriers in homeostasis and disease Annu Rev Pathol 5 2010 119 144
6. L.J. John, M. Fromm, and J.D. Schulzke Epithelial barriers in intestinal inflammation Antioxid Redox Signal 15 2011 1255 1270
7. T. Suzuki, N. Yoshinaga, and S. Tanabe IL-6 regulates claudin-2 expression and tight junction permeability in intestinal epithelium J Biol Chem 286 2011 31263 31271
8. L.E. Smythies, M. Sellers, R.H. Clements, M. Mosteller-Barnum, G. Meng, and W.H. Benjamin Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity J Clin Invest 115 2005 66 75
9. P.D. Smith, L.E. Smythies, R. Shen, T. Greenwell-Wild, M. Gliozzi, and S.M. Wahl Intestinal macrophages and response to microbial encroachment Mucosal Immunol 4 2011 31 42
10. N. Kamada, T. Hisamatsu, S. Okamoto, H. Chinen, T. Kobayashi, and T. Sato Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis J Clin Invest 118 2008 2269 2280
11. C.L. Leaphart, F. Qureshi, S. Cetin, J. Li, T. Dubowski, and C. Batey Interferon-γ inhibits intestinal restitution by preventing gap junction communication between enterocytes Gastroenterology 132 2007 2395 2411
12. R.J. Anand, S. Dai, C. Rippel, C. Leaphart, F. Qureshi, and S.C. Gribar Activated macrophages inhibit enterocyte gap junctions via the release of nitric oxide Am J Physiol Gastrointest Liver Physiol 294 2008 G109 G119
13. E. Cassol, S. Malfeld, P. Mahasha, S. van der Merwe, S. Cassol, and C. Seebregts Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy J Infect Dis 202 2010 723 733
14. C. Wallon, Y. Braaf, M. Wolving, G. Olaison, and J.D. Söderholm Endoscopic biopsies in Ussing chambers evaluated for studies of macromolecular permeability in the human colon Scand J Gastroenterol 40 2005 586 595
15. N.G. Sandler, C. Koh, A. Roque, J.L. Eccleston, R.B. Siegel, and M. Demino Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection Gastroenterology 141 2011 1220 1230
16. C. Guarner, J.M. González-Navajas, E. Sánchez, G. Soriando, R. Frances, and M. Chiva The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation Hepatology 44 2006 633 639
17. J. Fernández, M. Navasa, R. Planas, S. Montoliu, D. Monfort, and G. Soriano Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818 824
18. S.M. Riordan, and R. Williams The intestinal flora and bacterial infection in cirrhosis Hepatology 45 2006 744 757
19. R. Yang, T. Harada, J. Li, T. Uchiyama, Y. Han, and J.A. Englert Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism Intensive Care Med 31 2005 709 717
20. M. Schenk, A. Bouchon, F. Seibold, and C. Mueller Trem-1 expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases J Clin Invest 117 2007 3097 3106
21. S.Z. Sheikh, K. Matsuoka, T. Kobayashi, F. Li, T. Rubinas, and S.E. Plevy Cutting edge: IFN-γ is a negative regulator of IL-23 in murine macrophages and experimental colitis J Immunol 184 2010 4069 4073
22. A.R. Anand, M. Cucchiarini, E.F. Terwilliger, and R.K. Ganju The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells J Immunol 180 2008 5636 5644
23. H.M. Martin, B.J. Campbell, C.A. Hart, C. Mpofu, M. Nayar, and R. Singh Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer Gastroenterology 127 2004 80 93
24. P. Hartmann, M. Haimerl, M. Mazagova, D.A. Brenner, and B. Schnabl Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice Gastroenterology 143 2012 1330 1340
25. A.M. Marchiando, L. Shen, W.V. Graham, K.L. Edelblum, C.A. Duckworth, and Y. Guan The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding Gastroenterology 140 2011 1208 1218
26. S. Zeissig, N. Bürgel, D. Günzel, J. Richter, J. Mankertz, and U. Wahnschaffe Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease Gut 56 2007 61 72
27. A.J. Smith, T.W. Schacker, C.S. Reilly, and A.T. Haase A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection J Acquir Immune Defic Syndr 55 2010 306 315
28. S. Resta-Lenert, and K.E. Barrett Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2 Gastroenterology 122 2002 1070 1087
29. X. Han, M.P. Fink, R. Yang, and R.L. Delude Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice Shock 21 2004 261 270
30. S. Mishima, D. Xu, Q. Lu, and E.A. Deitch Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacterial overgrowth Arch Surg 132 1997 1190 1195